Company page

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics, Inc. (ticker: CVKD) is a public company operating in the American market, with a market capitalization of approximately $6.7 million. The company focuses on developing innovative therapies to address unmet medical needs. Investors can find more information about its operations and market presence on its dedicated company page.